Methods for in vitro joining and combinatorial assembly of nucleic acid molecules
The present invention relates to methods of joining two or more double-stranded (ds) or single-stranded (ss) DNA molecules of interest in vitro, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule of each pair share a region of sequence identity. The method allows the joining of a large number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes. It can be used, e.g., to join synthetically produced sub-fragments of a gene or genome of interest. Kits for performing the method are also disclosed. The methods of joining DNA molecules may be used to generate combinatorial libraries useful to generate, for example, optimal protein expression through codon optimization, gene optimization, and pathway optimization.
1. An in vitro method of joining a set of two or more double-stranded (ds) or single-stranded (ss) DNA molecules, wherein adjacent DNA molecules to be joined contain overlapping sequences at their termini, said method comprising contacting in vitro the two or more DNA molecules in a single vessel with
(a) an isolated non-thermostable 5′ to 3′exonuclease that lacks 3′ exonuclease activity,
(b) a crowding agent,
(c) an isolated thermostable non-strand-displacing DNA polymerase with 3′ exonuclease activity, or a mixture of said DNA polymerase with a second DNA polymerase that lacks 3′ exonuclease activity,
(d) an isolated thermostable ligase,
(e) a mixture of dNTPs, and
(f) a suitable buffer,
under conditions that are effective for joining the two or more DNA molecules to form a first assembled dsDNA molecule in a one-step reaction.
2. The method of claim 1 , wherein the exonuclease of (a) is a T5 exonuclease and said contacting is under isothermal conditions.
3. The method of claim 1 , wherein
the crowding agent of (b) is PEG, and/or
the non-strand-displacing DNA polymerase of (c) is PHUSION™ DNA polymerase or VENT® DNA polymerase, and/or the ligase of (d) is Taq ligase.
4. The method of claim 1 , wherein the conditions are also suitable for digesting any unpaired, non-homologous, single-stranded DNAs following the joining reaction.
5. The method of claim 4 , wherein at least some of the DNA molecules to be joined comprise, at one terminus, a sequence that is non-homologous to any of the DNA molecules of interest.
6. The method of claim 5 , wherein the non-homologous sequences comprise one or more binding regions for PCR primers, and/or regions of homology to vector sequences, and/or recognition sites for one or more restriction enzymes.
7. The method of claim 1 , further comprising repeating the method to join a second set of two or more DNA molecules to one another to obtain a second assembled DNA molecule, and then joining the first and the second assembled DNA molecules to obtain a third assembled ds DNA molecule.
8. A kit for a one-step in vitro reaction to join a set of two or more double-stranded (ds) or single-stranded (ss) DNA molecules, wherein adjacent DNA molecules to be joined contain overlapping sequences at their termini, comprising in a single vessel
(a) an isolated non-thermostable 5′ to 3′exonuclease that lacks 3′ exonuclease activity,
(b) a crowding agent,
(c) an isolated thermostable non-strand-displacing DNA polymerase with 3′ exonuclease activity, or a mixture of said DNA polymerase with a second DNA polymerase that lacks 3′ exonuclease activity,
(d) an isolated thermostable ligase,
in amounts such that when said two or more DNA molecules are added to the kit, in the presence of a suitable buffer solution and dNTPs, and incubated under isothermal conditions, the two or more DNA molecules are assembled in a concerted reaction.
9. The kit of claim 8 , comprising
(a) T5 exonuclease;
(b) PEG
(c) Phusion™ DNA polymerase, and
(d) Taq ligase.
10. A method of modifying the properties of a whole nucleic acid molecule, said method comprising:
(a) representationally dividing the nucleic acid sequence of said whole nucleic acid molecule into a multiplicity of portions along its length thereby identifying the sequences of partial nucleic molecules;
(b) providing, for at least 3 of said partial nucleic molecules, a multiplicity of variants of each partial nucleic acid molecule;
(c) combinatorially assembling in vitro said variants along with any partial nucleic acid molecules which are not varied, wherein the partial nucleic acid molecules or variants thereof contain overlapping sequences at their termini whereby assembly of the partial nucleic acid molecules and variants thereof in the mixture would result in assembly of a multiplicity of variants of the whole nucleic acid molecule; and
(d) expressing the variants of the whole nucleic acid molecule to determine any modified properties of said variants of said whole nucleic acid molecule; wherein the assembling of step (c) is performed by the method of claim 1 .
11. An in vitro method of joining a set of two or more double-stranded (ds) or single-stranded (ss) DNA molecules, wherein adjacent DNA molecules to be joined contain overlapping sequences at their termini, said method comprising contacting in vitro the two or more DNA molecules in a single vessel with
(a) an isolated non-thermostable 3′ to 5′ exonuclease active in the presence of dNTPs,
(b) a crowding agent,
(c) an isolated heat-activated DNA polymerase,
(d) an isolated thermostable ligase,
(e) a mixture of dNTPs, and
(f) a suitable buffer,
under conditions that are effective for joining the two or more DNA molecules to form a first assembled dsDNA molecule in a one-step thermocycled reaction.
12. The method of claim 11 , wherein the exonuclease of (a) is Exonuclease III.
13. The method of claim 11 , wherein polymerase of (c) is heat-activated by the removal of an inactivating moiety combined with the polymerase in a heat-sensitive manner.
14. The method of claim 11 , wherein
the crowding agent of (b) is PEG, and/or
the DNA polymerase of (c) is AMPLITAQ GOLD®, and/or
the ligase of (d) is Taq ligase.
15. The method of claim 11 , further comprising repeating the method to join a second set of two or more DNA molecules to one another to obtain a second assembled DNA molecule, and then joining the first and the second assembled DNA molecules to obtain a third assembled ds DNA molecule.
16. A kit for a one-step in vitro reaction to join a set of two or more double-stranded (ds) or single-stranded (ss) DNA molecules, wherein adjacent DNA molecules to be joined contain overlapping sequences at their termini, comprising in a single vessel
(a) an isolated non-thermostable 3′ to 5′ exonuclease active in the presence of dNTPs,
(b) a crowding agent,
(c) an isolated heat-activated DNA polymerase,
(d) an isolated thermostable ligase,
(e) a mixture of dNTPs, and
(f) a suitable buffer,
in amounts such that when said two or more DNA molecules are added to the kit, in the presence of a suitable buffer solution and dNTPs, and incubated under thermocycled conditions, the two or more DNA molecules are assembled in a concerted reaction.
17. A method of modifying the properties of a whole nucleic acid molecule, said method comprising:
(a) representationally dividing the nucleic acid sequence of said whole nucleic acid molecule into a multiplicity of portions along its length thereby identifying the sequences of partial nucleic molecules;
(b) providing, for at least 3 of said partial nucleic molecules, a multiplicity of variants of each partial nucleic acid molecule;
(c) combinatorially assembling in vitro said variants along with any partial nucleic acid molecules which are not varied, wherein the partial nucleic acid molecules or variants thereof contain overlapping sequences at their termini whereby assembly of the partial nucleic acid molecules and variants thereof in the mixture would result in assembly of a multiplicity of variants of the whole nucleic acid molecule; and
(d) expressing the variants of the whole nucleic acid molecule to determine any modified properties of said variants of said whole nucleic acid molecule; wherein the assembling of step (c) is performed by the method of claim 11 .
18. A method of modifying the properties of a whole nucleic acid molecule, said method comprising:
(a) representationally dividing the nucleic acid sequence of said whole nucleic acid molecule into at least 5 portions along its length thereby identifying the sequences of partial nucleic molecules;
(b) providing, for at least 3 of said partial nucleic molecules, a multiplicity of variants of the partial nucleic acid molecule;
(c) combinatorially assembling in vitro said variants along with any partial nucleic acid molecules which are not varied, wherein the partial nucleic acid molecules or variants thereof contain overlapping sequences at their termini whereby assembly of the partial nucleic acid molecules and variants thereof in the mixture would result in assembly of a multiplicity of variants of the whole nucleic acid molecule; and
(d) expressing the variants of the whole nucleic acid molecule to determine any modified properties of the variants of said whole nucleic acid molecule.
19. The method of claim 18 , wherein the variants of the partial nucleic acid molecule provide degenerate forms of the codon for one or more amino acids encoded by the partial nucleic acid molecules; or
wherein the variants of the partial nucleic acid molecule provide a multiplicity of nucleic acid control sequences affecting transcliption or translation of the whole nucleic acid molecule; or
wherein the variants of the partial nucleic acid molecule provide a multiplicity of regions encoding domains or motifs of peptides or proteins encoded by the whole nucleic acid molecule; or
wherein the peptides or proteins encoded by said partial nucleic acid molecules function together in a metabolic pathway.
20. A method of modifying the properties of a whole nucleic acid molecule, said method comprising:
(a) representationally dividing the nucleic acid sequence of said whole nucleic acid molecule into a multiplicity of portions along its length thereby identifying the sequences of partial nucleic molecules;
(b) providing, for at least 3 of said partial nucleic molecules, a multiplicity of variants of the partial nucleic acid molecule;
(c) combinatorially assembling in vitro said variants along with any partial nucleic acid molecules which are not varied, wherein the partial nucleic acid molecules or variants thereof contain overlapping sequences at their termini whereby assembly of the partial nucleic acid molecules and variants thereof in the mixture would result in assembly of a multiplicity of variants of the whole nucleic acid molecule; and
(d) expressing the variants of the whole nucleic acid molecule to determine any modified properties of the variants of said whole nucleic acid molecule;
wherein the variants of the partial nucleic acid molecule provide degenerate forms of the codon for one or more amino acids encoded by the partial nucleic acid molecules, or
wherein the variants of the partial nucleic acid molecule provide a multiplicity of nucleic acid control sequences affecting transcription or translation of the whole nucleic acid molecule, or
wherein the variants of the partial nucleic acid molecule provide a multiplicity of regions encoding domains or motifs of peptides or proteins encoded by the whole nucleic acid molecule, or
wherein peptides or proteins encoded by said partial nucleic acid molecules function together in a metabolic pathway.